DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alimera Sciences, Inc. (ALIM)
« Back to company indexALIM Chatter Timeline
Stock Ticker for ALIM
Most Active Tweeters for ALIM
| User | Tweets |
|---|---|
| @arhamgrowthcap | 2 |
| @COCKRELLGROUP | 1 |
| @ez_alertz | 1 |
| @StockNewsNow | 1 |
| @filingsdb | 1 |
Recent Tweets for ALIM
 |
@newswithvalue $ALIM: What Type Of Shareholder Owns Alimera Sciences, Inc.’s (NASDAQ …: https://t.co/G7GRnvqPkX June 12th 2019, 3:06pm |
 |
@Swan827 RT @arhamgrowthcap: Gave a shot at modeling $ALIM and I still need to see the comparable data but I can already make the case it's at least… June 10th 2019, 4:06pm |
 |
@arhamgrowthcap Gave a shot at modeling $ALIM and I still need to see the comparable data but I can already make the case it's at least 50-75% undervalued June 10th 2019, 4:06pm |
|
@arhamgrowthcap I'm very interested in growing my $ALIM position. Great company and the stock has literally everything I look for.… https://t.co/qZeo11Kxi1 June 8th 2019, 6:06pm |
 |
@MaisaCorp $ALIM plans to start selling its Iluvien treatment for non-infectious uveitis, a swelling of the eye, in Europe in H2 2019. June 6th 2019, 1:06pm |
 |
@StockNewsNow $ALIM Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Recurren… https://t.co/Xwd2SXLK7H June 6th 2019, 10:06am |
 |
@COCKRELLGROUP Alimera $ALIM announce: 3 Yr Clinical Trial Results Support ILUVIEN® Launch in Europe for Prevention of Relapse in… https://t.co/vW6LgSXPEt June 6th 2019, 9:06am |
 |
@Allstocknews $ALIM Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Re From our Stock News Alerts App June 6th 2019, 8:06am |
 |
@marketexclusive $ALIM ALIMERA SCIENCES, INC. (NASDAQ:ALIM) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued List… https://t.co/4ZvOGmsi3R June 5th 2019, 6:06am |
 |
@Stock_News_Now $ALIM: New SEC Filing for ALIM: Form 8-K (No. 0001267602-19-000079): https://t.co/M67TPFHokM June 4th 2019, 5:06pm |
 |
@StockTexts $ALIM Alimera Sciences, Inc. SEC Filing: Form 8-K https://t.co/WMTio3A87n June 4th 2019, 5:06pm |
 |
@filingsdb New Form 8-K filed by ALIMERA SCIENCES INC $ALIM - https://t.co/edSO2U6Z9Q June 4th 2019, 5:06pm |
 |
@ez_alertz $ALIM Alimera Sciences Sees Hammer Chart Pattern: Time to Buy? https://t.co/NBkLQHHKKB June 4th 2019, 6:06am |
 |
@TickerReport Alimera Sciences Inc $ALIM Given Average Rating of “Buy” by Analysts https://t.co/C7PYqozJIQ June 3rd 2019, 9:06pm |
 |
@bbnsnews Brokerages Anticipate Alimera Sciences Inc $ALIM Will Post Quarterly Sales of $12.97 Million https://t.co/0rQkFxYWsT June 3rd 2019, 9:06pm |
|
@arhamgrowthcap @100BaggerHunter Thomas, $ALIM expects to be profitable at a level of $13.5M in sales for a quarter. Last quarter t… https://t.co/dxxqiZVEwb June 3rd 2019, 5:06pm |
 |
@EnterpriseLeade Head to Head Analysis: Alimera Sciences $ALIM vs. Mallinckrodt $MNK https://t.co/TJb5uT2kAW June 3rd 2019, 2:06am |
 |
@registrarjourn Head to Head Analysis: Alimera Sciences $ALIM vs. Mallinckrodt $MNK https://t.co/WnCr9eUeFA June 3rd 2019, 2:06am |
 |
@OlympiaReport Alimera Sciences $ALIM Now Covered by Analysts at Craig Hallum https://t.co/r6CZmOiZCz June 1st 2019, 5:06am |
 |
@ThisLincolnian Alimera Sciences $ALIM Now Covered by Analysts at Craig Hallum https://t.co/3A3B2WtvPx June 1st 2019, 5:06am |
 |
@WeekHerald Alimera Sciences $ALIM Now Covered by Analysts at Craig Hallum https://t.co/PPiJ4MMeb1 June 1st 2019, 5:06am |
 |
@ConsumerFeed -$0.04 EPS Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/hj8izsdXon May 30th 2019, 9:05am |
 |
@AmericanBanking Contrasting Mallinckrodt $MNK & Alimera Sciences $ALIM https://t.co/p2YRGlGB7P #stocks May 29th 2019, 4:05pm |
|
@arhamgrowthcap $ALIM met with management last week at B. Riley. Great healthcare company no more testing nor approval required. Ba… https://t.co/86qnCbA3tC May 29th 2019, 7:05am |
|
@AmericanBanking $12.97 Million in Sales Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/PWttTEeiaY #stocks May 29th 2019, 3:05am |
|
@ConsumerFeed Craig Hallum Begins Coverage on Alimera Sciences $ALIM https://t.co/1Bs6ZUn0eQ May 29th 2019, 3:05am |
|
@AmericanBanking Alimera Sciences $ALIM Now Covered by Analysts at Craig Hallum https://t.co/xxrXPGch6s #stocks May 28th 2019, 8:05am |
 |
@firsttomarkets Alimera Sciences Inc Initiated Coverage by Craig-Hallum (Ranked 52nd) to Buy $ALIM #ALIM https://t.co/sutdsaDAHl May 28th 2019, 8:05am |
 |
@Briefingcom $ALIM: Craig Hallum starts at Buy May 28th 2019, 7:05am |
 |
@dailypoliticaln Zacks: Analysts Expect Alimera Sciences Inc $ALIM Will Post Earnings of -$0.04 Per Share https://t.co/bXxpEGfbew May 27th 2019, 10:05am |
|
@AmericanBanking Alimera Sciences Inc $ALIM Expected to Announce Earnings of -$0.04 Per Share https://t.co/2vDgyoCbuH #stocks May 27th 2019, 10:05am |
|
@AmericanBanking Alimera Sciences Inc $ALIM Receives Average Recommendation of “Buy” from Brokerages https://t.co/YAzJjt2kg9 #stocks May 27th 2019, 8:05am |
 |
@betrbiz RT @Allstocknews: $ALIM Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educat From our St… May 22nd 2019, 1:05pm |
|
@StockNewsNow $ALIM Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educate Cons… https://t.co/S9S7y0BwUZ May 22nd 2019, 10:05am |
|
@COCKRELLGROUP $ALIM Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educate Consumers on Diabetic… https://t.co/SOsf45jzU2 May 22nd 2019, 9:05am |
 |
@VisualStockRSRC $ALIM - Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and https://t.co/FoWbMg2BNf May 22nd 2019, 8:05am |
|
@Allstocknews $ALIM Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educat From our Stock News Alerts App May 22nd 2019, 8:05am |
 |
@SwingTradeBot 20 DMA Support today: $ALIM ... https://t.co/deOpbNqdR6 May 21st 2019, 12:05pm |
|
@ez_alertz $ALIM Top Ranked Momentum Stocks to Buy for May 21st https://t.co/8fGfsaQMrz May 21st 2019, 10:05am |
 |
@HottestStockNow $ALIM to Present a Corporate Overview at Upcoming Investor Conference https://t.co/qkHEedX03S May 15th 2019, 7:05am |
|
@StockNewsNow $ALIM Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019 https://t.co/IqlolEpFv0 May 14th 2019, 10:05am |
|
@COCKRELLGROUP Alimera Sciences $ALIM Present at 20th Annual B. Riley FBR Inst. Investor Conf. May 22 President & CEO, Rick Eiswir… https://t.co/VXqUcolr3l May 14th 2019, 9:05am |
|
@ez_alertz $ALIM Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019 https://t.co/B7uWpv2DmU May 14th 2019, 8:05am |
|
@Allstocknews $ALIM Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22 From our Stock News Alerts App May 14th 2019, 8:05am |
 |
@dispatchtribune $12.25 Million in Sales Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/pkektzOWvj May 11th 2019, 7:05pm |
|
@registrarjourn Zacks: Analysts Expect Alimera Sciences Inc $ALIM Will Post Earnings of -$0.06 Per Share https://t.co/lfm8dxYv1F May 11th 2019, 7:05pm |
|
@EnterpriseLeade Zacks: Analysts Expect Alimera Sciences Inc $ALIM Will Post Earnings of -$0.06 Per Share https://t.co/sZcywWIwGM May 11th 2019, 7:05pm |
|
@ThisLincolnian Analysts Set Alimera Sciences Inc $ALIM Price Target at $2.92 https://t.co/ilQf2h5QoD May 9th 2019, 10:05pm |
|
@dailypoliticaln $12.25 Million in Sales Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/disk1I3xwu May 9th 2019, 3:05pm |
|
@TickerReport -$0.06 EPS Expected for Alimera Sciences Inc $ALIM This Quarter https://t.co/BU2YAEnE0m May 9th 2019, 3:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.